EOS imaging Announces €21.8 Million 2015 Revenue

EOS Imaging
share Share

Stable sales of equipment impacted by the last quarter

Strong growth in North America

EOS imaging (Paris:EOSI), the pioneer in 2D/3D orthopaedic medical imaging has announces its consolidated revenue for the fourth quarter and full year ended December 31, 2015.

In millions of euros     2014   2013    Change (%)
Equipment sales     17,9   17,3   4%
% of total revenue     82%   86%   -
Sales of maintenance contracts3,092,1047%
% of total revenue     14%   11%   -
Sales of consumables and services0,830,769%
% of total revenue     4%   3%    
Total revenue     21,8   20,1   9%
Non audited data
  • 2015 revenue stable, affected by an exceptionally low last quarter

EOS imaging recorded annual revenue of €21.8 million in 2015, up 9% compared to 2014. In 2014 and 2015, the Company sold 44 EOS® systems.

Revenue from equipment sales was €17.9 million in 2015, up 4% compared to 2014. The average selling price was €406,000 per system, up 4% from 2014.

Recurring revenues were up 36%. Sales of maintenance contracts increased by 47% to €3.09 million. Sales of consumables and services totalled €0.83 million, compared with €0.76 million in 2014.

  • Growth in North America partially offset by lower sales in Asia-Pacific
In millions of euros    2015   2014    Change (%)
EMEA    9,19   8,62   7%
North America10,45,9675%
Asia-Pacific    2,21   5,53   -60%
Total revenue    21,8   20,11   9%
Non audited data  

In 2015, EOS imaging recorded revenue of €2.21 million in Asia-Pacific, a decrease of 60%, following a strong entry into this market in 2014. In the second half of 2015, the Company experienced disruption in Japan, a key market, due to a transition with its commercial organization, which the Company expects will have a positive impact on results in Japan in 2016. The Company also anticipates that it will receive regulatory approval for the EOS system in China in 2016, providing another growth opportunity in the Asia-Pacific region.

In Europe and the Middle East, EOS imaging recorded €9.19 million sales, growth of 7% associated with low closing activity at the end of the year. The reinforcement of the salesforce implemented in the second half of 2015 will allow the Company to return to stronger growth in Europe and the Middle East in 2016.

EOS imaging recorded revenue of 10.4 million in North America, representing growth of 75% compared to 2014, demonstrating accelerated momentum in the largest market opportunity for the Company despite lower than anticipated results in one significant US region.

  • 14 systems sold in the fourth quarter of 2015
In millions of euros     2015   2014
     Q1   Q2   Q3   Q4   Q1   Q2   Q3   Q4
Equipment sales2,50   6,00   3,79   5,581,56   4,30   3,22   8,19
% of total revenue     75%   87%   80%   81%   72%   87%   82%   90%
Sales of maintenance contracts0,630,690,721,050,450,480,560,61
% of total revenue     19%   10%   15%   15%   21%   10%   14%   7%
Sales of consumables and services0,190,190,230,220,150,170,150,29
% of total revenue     6%   3%   5%   3%   7%   3%   4%   3%
Total revenue     3,32   6,88   4,74   6,85   2,16   4,96   3,93   9,08

Non audited data

      

EOS imaging sold 14 systems and recorded revenue of €6.85 million in the fourth quarter of 2015, down 25% compared with the fourth quarter of 2014.

  • Perspectives

Marie Meynadier, CEO of EOS imaging, said: “Our 2015 revenue results reflect continued positive momentum in the key North America region, partially offset by lower sales in the Asia-Pacific region and lower than anticipated fourth quarter results. Historically, a very significant part of our system sales are closed in the fourth quarter, and particularly in month of December, when most commercial negotiations are concluded. This year we closed fewer system sales than anticipated in December, which impacted our 2015 revenue. In addition, we have revised some components of our marketing and sales organization in the second half of the year and are currently finishing these revisions to better support our growth. This, and the strong signs of EOS continued adoption as a standard of care, highlighted by leading institutions offering the EOS system, including several with multiple systems, gives us confidence that we will regain commercial momentum in 2016 that is in line with our growth ambitions.”

Source & Image Credit : EOS Imaging

Published on : Thu, 7 Jan 2016



Related Articles
EOS imaging Announces Exclusive Licensing and Partnership in Surgical Simulation

EOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, has announced a new... Read more

EOS imaging

Status will allow specific reimbursement codes for EOS® exams in Korea EOS imaging (Euronext, FR0011191766 – EOSI), the... Read more

EOSapps Suite for Spine, Hip and Knee Surgery Planning to be Featured along with the EOS System at the American Academy of... Read more

EOS Imaging, Financial Report, Medical Imaging, 2D/3D orthopedic EOS imaging (Paris:EOSI), the pioneer in 2D/3D orthopaedic medical imaging has announces its consolidated revenue for the fourth quarter and full year ended December 31, 2015.

No comment


Please login to leave a comment...

Highlighted Products